Atlas Trials

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01955434 · COMPLETED

Trial details

NCT number
NCT01955434
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Start date
2013-11-01
Primary completion
2016-06-09
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.